Biomarkers 2024

02.23.2024 | London | Community

Biomarkers 2024, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions working across multiple therapeutic areas and stages of drug development.

Expand your knowledge & discuss future priorities in:
– Biomarkers: Identification, Validation, & Translation in Oncology
– Biomarker for Diagnostics & Precision Medicine
– Biomarkers for Clinical Development
– Biomarkers: Identification, Validation & Translation in Neuroscience, NASH & Co- Morbidity
– New Emerging Biomarker Technologies
– Digital Pathology and AI-Based Technologies for Biomarker Research

Meet key decision makers representing large phama & biotech companies:
– Stephen Laroux (Scientific Director, Research Fellow, Precision Medicine – Immunology, Abbvie Bioresearch Center
– Neil Humphryes- Kirilov (Associate Director of Human Genomics, C4X Discovery)
– Alexandra Sevko (Director, Translational Research, Prokarium)
– Gerard Sanderink (Global Head Biomarkers & Clinical Bioanalyses, Sanofi)
– Richard Torstenson (Senior Regulatory Affairs Director, AstraZeneca)
& many more!

View the agenda here: https://www.oxfordglobal.co.uk/biomarkers-series-uk/agenda/download-agenda/?utm_source=ebrc&utm_medium=eventlisting&utm_campaign=biomarkers&utm_content=biomuk2024

For more information contact marketing@oxfordglobal.co.uk